ORLY
48
3
PRU
39
3
LNC
28
3
STX
34
2
EXPD
29
2
EMN
40
5
BAC
38
3
MTB
38
4
MDLZ
28
2
HRB
40
3
ES
12
3
NWSA
69
4
JCI
44
7
TRV
34
4
MRK
25
2
CRM
65
6
PVH
58
5
EQR
33
6
IP
53
3
FOXA
67
5
ORLY
48
3
PRU
39
3
LNC
28
3
STX
34
2
EXPD
29
2
EMN
40
5
BAC
38
3
MTB
38
4
MDLZ
28
2
HRB
40
3
ES
12
3
NWSA
69
4
JCI
44
7
TRV
34
4
MRK
25
2
CRM
65
6
PVH
58
5
EQR
33
6
IP
53
3
FOXA
67
5
Financhill
Back

NLS Pharmaceutics Quote, Financials, Valuation and Earnings

The 7 new tech giants dominating today's markets

Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Sell
28

NLSP
NLS Pharmaceutics

Last Price:
$1.91
Seasonality Move:
0.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.

NLS Pharmaceutics Price Quote

$1.91
-0.01 (-19.75%)
(Updated: December 21, 2024 at 5:39 AM ET)

NLS Pharmaceutics Key Stats

Sell
28
NLS Pharmaceutics (NLSP) is a Sell
Day range:
$1.78 - $2.29
52-week range:
$1.73 - $24.34
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
258K
Avg. volume:
375.7K
1-year change:
-89.45%
Market cap:
$7.3M
Revenue:
$0
EPS:
$-6.74

How Much Does NLS Pharmaceutics Make?

Data Unavailable

Is NLS Pharmaceutics Growing As A Company?

Data Unavailable

NLS Pharmaceutics Stock Price Performance

  • Did NLS Pharmaceutics Stock Go Up Last Month?
    NLS Pharmaceutics share price went down by -41.64% last month
  • Did NLSP's Share Price Rise Over The Last Year?
    NLSP share price fell by -89.45% over the past 1 year

What Is NLS Pharmaceutics 52-Week High & Low?

NLS Pharmaceutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy NLS Pharmaceutics?

Data Unavailable

Is NLS Pharmaceutics Cash Flow Positive?

Data Unavailable

NLS Pharmaceutics Return On Invested Capital

Data Unavailable

NLS Pharmaceutics Earnings Date & Stock Price

NLS Pharmaceutics Competitors

  • Who Are NLS Pharmaceutics's Competitors?
    Below is a list of companies who compete with NLS Pharmaceutics or are related in some way:
    • AC Immune SA (ACIU)
    • Addex Therapeutics Ltd (ADXN)
    • CRISPR Therapeutics AG (CRSP)
    • MoonLake Immunotherapeutics (MLTX)
    • Molecular Partners AG (MOLN)

NLS Pharmaceutics Dividend Yield

Data Unavailable

NLS Pharmaceutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable